Anthem Biosciences
add_icon

Anthem Biosciences

628.45
-16.40
(-2.54%)
Market Cap
35,294.38 Cr
PE Ratio
74.84
Volume
1,66,996.00
Day High - Low
635.80 - 625.20
52W High-Low
873.50 - 579.15
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
35,294.38 Cr
EPS
8.07
PE Ratio
74.84
PB Ratio
13.18
Book Value
49.00
EBITDA
756.60
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
18.73
Debt to Equity
0.08
Analyst Rating and Forecast
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Anthem Biosciences announces resignation of General Counsel K. Ramakrishnan effective March 31, 2026, after nearly two decades with the company, citing superannuation following the company's listing.
neutral
Anthem Biosciences executed First Amendment to loan agreement with wholly owned subsidiary Neoanthem Lifesciences, enabling conversion of additional Rs 275 crores loan into equity shares within Rs 550 crores sanctioned limit.
negative
Anthem Biosciences reported consolidated net profit of ₹928 million in Q3, down from ₹1.2 billion in the same quarter last year, marking a year-on-year decline.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
628.45
#1 35,294.38
#3 74.84
#1 1,930.30
#1 30.15
#1 451
#3 -25.34
38.81
266.80
2,986.21
19.66
670.00
1.44
134
11.05
34.51
101.00
131.30
-561.11
4.30
-
0
0.00
17.72
24.81
55.04
#1 12.71
51.50
13.19
7
#1 62.50
42.61
0.56
22.31
-59.00
24.40
14.55
0
-62.50
37.45
28.56
8.70
-190.40
0.80
#1 300.00
0
-100.00
60.12

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
30.15 %
Net Income Growth
22.87 %
Cash Flow Change
198.49 %
ROE
-1.83 %
ROCE
13.75 %
EBITDA Margin (Avg.)
2.22 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
358
553
522
497
563
598
457
Expenses
218
330
338
288
349
332
291
EBITDA
140
223
184
209
214
266
165
Operating Profit %
36 %
37 %
32 %
40 %
35 %
40 %
31 %
Depreciation
19
20
20
30
27
34
35
Interest
4
4
3
1
2
3
0
Profit Before Tax
118
200
161
178
186
230
131
Tax
36
38
37
96
51
56
38
Net Profit
82
162
124
83
136
173
93
EPS in ₹
1.47
2.90
2.22
1.48
2.43
3.09
1.65

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
787
1,034
1,619
2,015
2,398
2,808
Fixed Assets
306
361
329
449
483
705
Current Assets
403
616
1,098
1,323
1,482
1,737
Capital Work in Progress
50
19
154
164
345
297
Investments
99
209
273
499
472
433
Other Assets
333
445
863
903
1,099
1,373
Total Equity & Liabilities
787
1,034
1,619
2,015
2,398
2,808
Current Liabilities
247
285
223
164
339
326
Non Current Liabilities
118
47
41
110
135
72
Total Equity
422
702
1,355
1,741
1,925
2,410
Reserve & Surplus
414
693
1,346
1,627
1,813
2,298
Share Capital
8
9
9
114
112
112

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
9
18
308
-6
-159
133
Investing Activities
-109
-196
-205
-376
-222
-152
Operating Activities
166
278
333
306
140
418
Financing Activities
-48
-63
181
64
-77
-134

Share Holding

% Holding
Dec 2024
Jul 2025
Sept 2025
Dec 2025
Promoter
77.23 %
76.88 %
74.69 %
74.69 %
FIIs
0.00 %
0.00 %
1.67 %
1.36 %
DIIs
0.00 %
0.00 %
7.22 %
7.60 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
9.61 %
9.60 %
Others
22.77 %
23.12 %
6.81 %
6.74 %
No of Share Holders
16
761
2,17,681
1,99,492

Announcements

Announcement under Regulation 30 (LODR)-Cessation10 days ago
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations)Feb 23, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Feb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 05, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 05, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Feb 05, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 05, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday February 05 2026Feb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 27, 2026
Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Jan 27, 2026
Compliance Certificate Under Regulation 74(5) Of SEBI (DP) Regulations 2018Jan 07, 2026
Intimation Under Regulation 30 Of SEBI LODR Regulations With Reference To Issuance Of Corporate GuaranteeJan 07, 2026
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 15, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 12, 2025
Intimation Of Violation Under CompanyS Code Of Conduct To Regulate Monitor And Report Trading By Designated Persons As Required Under SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations)Nov 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 08, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 08, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday November 08 2025Nov 08, 2025
Outcome Of The Board Meeting Held On Saturday November 08 2025Nov 08, 2025
Intimation Of Violation Under CompanyS Code Of Conduct To Regulate Monitor And Report Trading By Designated Persons As Required Under SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations)Oct 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 23, 2025
Board Meeting Intimation for The Financial Results For Quarter And Half Year Ended September 30 2025Oct 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 06, 2025
Closure of Trading WindowSep 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 19, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 15, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2025
Outcome Of Board Meeting Held On Wednesday August 13 2025Aug 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday August 13 2025Aug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 08, 2025
Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025Aug 08, 2025
Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosures Requirements) Regulation 2015Jul 21, 2025
Announcement Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosures Requirements) Regulation 2015Jul 21, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jul 21, 2025
Closure of Trading WindowJul 21, 2025
Appointment of Company Secretary and Compliance OfficerJul 21, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Mahindra Manulife Innovation Opportunities Fund Direct-Growth
1.36%
31500
1.36%
1.36%
PGIM India Multi Asset Allocation Fund Direct - Growth
0.40%
1724
0.07%
-0.04%
360 ONE Flexicap Fund Direct - Growth
0.54%
0
0.00%
0.08%
Aditya Birla Sun Life ELSS Tax Saver Direct-Growth
0.00%
0
0.00%
0.00%
Aditya Birla Sun Life Equity Hybrid '95 Fund Direct-Growth
0.29%
0
0.00%
0.04%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Business Cycles Fund Direct-Growth
0.62%
0
0.00%
0.11%
Axis ELSS Tax Saver Direct Plan-Growth
0.32%
0
0.00%
0.06%
Axis Large & Mid Cap Fund Direct-Growth
0.17%
0
0.00%
0.02%
Axis Midcap Direct Plan-Growth
0.14%
0
0.00%
0.02%
Axis Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.54%
0
0.00%
0.04%
Bandhan Midcap Fund Direct-Growth
0.68%
0
0.00%
0.08%
Edelweiss Aggressive Hybrid Fund Direct - Growth
0.00%
0
0.00%
0.00%
Edelweiss Balanced Advantage Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Equity Savings Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Mid Cap Direct Plan-Growth
0.00%
0
0.00%
0.00%
Edelweiss Recently Listed IPO Fund Direct-Growth
2.55%
0
0.00%
0.34%
Franklin India Mid Cap Fund Direct-Growth
0.23%
0
0.00%
0.00%
Groww Multicap Fund Direct-Growth
1.37%
0
0.00%
0.02%
HDFC Business Cycle Fund Direct - Growth
3.53%
0
0.00%
0.54%
HDFC Dividend Yield Fund Direct - Growth
0.22%
0
0.00%
0.03%
HDFC ELSS Tax Saver Fund Direct Plan-Growth
0.21%
0
0.00%
0.03%
HDFC Innovation Fund Direct-Growth
1.30%
0
0.20%
0.15%
HDFC Manufacturing Fund Direct - Growth
1.02%
0
0.00%
0.16%

Technical Indicators

RSI(14)
Neutral
44.40
ATR(14)
Less Volatile
21.50
STOCH(9,6)
Neutral
42.08
STOCH RSI(14)
Oversold
18.34
MACD(12,26)
Bearish
-4.60
ADX(14)
Strong Trend
31.04
UO(9)
Bearish
59.38
ROC(12)
Downtrend And Accelerating
-3.40
WillR(14)
Neutral
-59.12